Development and Pharmacological Characterization of Selective. Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in
|
|
- Maria Burns
- 5 years ago
- Views:
Transcription
1 SUPPORTING INFORMATION Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain Margherita Brindisi, Samuele Maramai, Sandra Gemma, Simone Brogi, Alessandro Grillo, Lorenzo Di Cesare Mannelli, Emanuele Gabellieri, Stefania Lamponi, Simona Saponara, Beatrice Gorelli, Daniele Tedesco, Tommaso Bonfiglio, & Christophe Landry, Kwang-Mook Jung, Andrea Armirotti, Livio Luongo, # Alessia Ligresti, Fabiana Piscitelli, Carlo Bertucci, Marie-Pierre Dehouck, Giuseppe Campiani,, * Sabatino Maione, # Carla Ghelardini, Anna Pittaluga, &, Daniele Piomelli, Vincenzo Di Marzo, and Stefania Butini *To whom correspondence may be addressed: , campiani@unisi.it; Tel Figures S1-S10 Tables S1-S6 1 H and 13 C NMR spectra of compounds (±)-4a, (±)-5a and (±)-6a Elemental analysis 1
2 Revised pharmacophore model for 3,4-disubstituted β-lactam-based MGL Inhibitors. Our revised pharmacophore model for 3,4-disubstituted β-lactam-based MGL Inhibitors consists in the combination of appropriate aromatic systems geometry with a suitable linker and a polar functionality, to establish interactions with Ser122. This model allowed us to attain potency and selectivity. In fact, the key feature of the trans 3,4-disubstituted β-lactam system of compounds 4a-h is the longer distance between the centroids of the aromatic systems (~7 Å) compared to the diphenylmethane scaffold of JZL184, SAR629 and JJKK048 (5-6 Å) (Figure S1), which may provide improvement in MGL inhibition potency. The spatial arrangement of the aryl moieties, constrained by a dihedral angle of 119.4, is critical to maximize the interaction with the hydrophobic pockets of the enzyme and provides the correct accommodation of the molecule within the catalytic site. Figure S1. Pharmacophoric model proposed for diphenylmethane-based MGL inhibitors, revised pharmacophore distances, spatial arrangement of the key structural motifs of 4a in its lower energy 2
3 conformation (relevant interactions with catalytic site residues of the enzyme are highlighted in black). HPLC separation of racemic mixture (±)-6a Figure S2. HPLC separation of racemic mixture (±)-6a. and analytical control of optical purity for compounds (+)-6a and (-)-6a. 3
4 Top-down and bottom-up proteomics studies Purified rmgl was incubated with 4a (1 h at 37 C, 1:10 molar ratio) and the intact MGL mass was determined by high-resolution mass spectrometry. From the multiply charged mass spectrum of naïve MGL (Figure 2A), incubated with DMSO as vehicle, we calculated a deconvoluted mass of 35,528 Da. A corresponding deconvoluted mass of 35,922 Da was observed for MGL following incubation with 4a (Figure 2B), indicating a mass increase of 394 Da, which is consistent with a covalent interaction with 4a. This result suggests that the hydroxyl group of the catalytic serine may carry out a nucleophilic attack on the ureidic portion of 4a, thereby producing a net increase of +C 22 H 20 FN 2 O 4 in the brute formula of MGL. Accordingly, this corresponds to a mass increase of Da on the intact protein mass (Figure 2C). Our results also indicate that a full conversion of naïve MGL to the covalent MGL-4a adduct was achieved with 1:1 stoichiometry under the assay conditions. We also performed bottom-up proteomic analyses to map the binding site of 4a in MGL. After digesting MGL with trypsin, analysis of the tryptic fragments identified the peptide as an adduct with compound 4a, because its mass shifted from 5,330 Da to 5,724 Da, with a net increase of +394 Da. This peptide contains six serine residues, including the catalytic Ser122. Tandem mass analysis carried out on charge state 5 precursor ions of the naïve and modified peptide allowed us to unequivocally assign Ser122 as the site of modification induced by the nucleophilic attack on the urea moiety of 4a. Results of tandem mass analysis are reported in Figures S2-S5. 4
5 Figure S3. Bottom-up proteomics analysis for the 4a-MGL interaction. Figure S4. Bottom-up proteomics analysis for 4a-MGL interaction. 5
6 Figure S5. Tandem mass analysis for the 4a-MGL binding site mapping. Figure S6. Tandem mass analysis for the 4a-MGL binding site mapping 6
7 Pharmacokinetic profiling of 4a. A B Peak area Solubility Peak area Solubility Chem. Stability (µm) (µm) (% remaining) ph = 7.4 ph = 3.0 ph = C Metabolic Stability Permeability on CYP3A assay (PAMPA) (% remaining) P e (x10-6 cm/sec) Figure S7. Pharmacokinetic profiling of 4a. (A) solubility and chemical stability, (B) metabolic stability on human CYP3A4; (C) permeability assay (PAMPA). 7
8 Analgesic effect of 4a in the mouse Hot plate test Table S1. Analgesic effect of acute administration of 4a in the mouse Hot plate test Hot plate (s) Treatment Before treatment After treatment 15 min 30 min 45 min 60 min 4a 3 mg kg -1 p.o ± ± ± ± ± 2.2 4a 10 mg kg -1 p.o ± ± ± ± ± 0.8 Compounds were suspended in 1% carboxymethylcellulose sodium salt (CMC) and administered (p.o.). Pain-related behavior (i.e. lifting and licking of the hind paw) were observed and the time (seconds) of the first sign was recorded. **P<0.01 and *P<0.05 in respect to the value before treatment. Each value represents the mean of 12 mice. 8
9 Determination of the absolute configuration of (3R,4S)-6a. Figure S8. Arbitrary atom numbering scheme for compound (3R,4S)-6a. Table S2. List of dihedral angles used for the conformational analysis on compound (3R,4S)-6a. Label ψ α φ 1 φ 2 φ 3 β 1 β 2 Dihedral angle O5 C2 N1 C6 C2 C3 C10 C11 C2 N1 C6 C7 N1 C6 C7 C8 C6 C7 C8 N9 N1 C4 C12 C13 C13 C14 O15 C16 9
10 Figure S9. Graphical representation of the dihedral angles used for the conformational analysis on compound (3R,4S)-6a. Table S3. Geometric parameters for the conformers of compound (3R,4S)-6a, as obtained by conformational analysis after B97D/TZ2P optimization. RMSD values below 0.1 Å are also reported. Conf. ID ψ (deg) α (deg) φ 1 (deg) φ 2 (deg) φ 3 (deg) β 1 (deg) β 2 (deg) Smallest RMSD (Å) (R,S)-6a (R,S)-6a4, (R,S)-6a (R,S)-6a5, (R,S)-6a (R,S)-6a1, (R,S)-6a (R,S)-6a1, (R,S)-6a (R,S)-6a2, (R,S)-6a (R,S)-6a8, (R,S)-6a (R,S)-6a (R,S)-6a6, (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a
11 Table S4. Free energies and Boltzmann populations at K and 1 bar for the conformers of compound (3R,4S)-6a, as obtained after B97D/TZ2P optimization. MM energies are also reported. Conf. ID χ (%) G (kcal mol 1 ) G (Ha) E MM (kcal mol 1 ) (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a (R,S)-6a Figure S10. Optimized structure of the lowest-energy conformer of compound (3R,4S)-6a, (R,S)- 6a13. 11
12 Table S5. Rotational strengths in dipole velocity formalism (R j ) and excitation wavelengths (λ j ) for the first 50 excited states of the conformers of compound (3R,4S)-6a, as obtained by PBE0/TZ2P//B97D/TZ2P calculations. J R j, erg cm 3 (λ j, nm) (R,S)-6a (R,S)-6a2 (R,S)-6a3 (R,S)-6a5 (R,S)-6a (262.71) (265.58) (262.91) (265.60) (265.25) (251.80) (249.24) (252.14) (249.35) (256.41) (248.84) (239.11) (248.87) (239.12) (250.63) (238.98) (238.75) (238.98) (238.75) (238.02) (234.69) (232.59) (235.03) (232.62) (233.62) (223.68) (229.11) (223.81) (229.21) (228.78) (222.96) (223.49) (222.98) (223.62) (223.14) (221.46) (222.83) (221.49) (222.74) (221.54) (216.83) (216.44) (216.79) (216.32) (219.59) (214.22) (215.89) (214.18) (215.92) (219.08) (213.13) (213.39) (213.12) (213.42) (217.83) (212.02) (212.25) (212.07) (212.24) (212.38) (210.06) (209.83) (210.03) (209.86) (210.36) (209.85) (208.75) (209.97) (208.69) (207.91) (206.77) (205.68) (206.96) (205.89) (207.78) (206.25) (204.73) (206.20) (204.53) (206.59) (205.12) (203.80) (205.12) (203.73) (204.90) (202.29) (203.27) (202.36) (203.40) (204.18) (200.56) (201.11) (200.68) (201.15) (201.22) (200.18) (199.25) (200.13) (199.30) (201.18) (198.78) (197.31) (198.80) (197.24) (200.43) (195.97) (195.16) (196.19) (195.23) (196.02) (194.09) (192.71) (194.20) (192.87) (194.13) (191.25) (192.31) (191.33) (192.42) (191.66) (188.17) (191.68) (188.28) (191.70) (189.09) (187.83) (188.98) (187.84) (188.99) (188.29) (186.52) (187.84) (186.55) (187.81) (186.37) (186.50) (184.29) (186.48) (184.23) (185.47) (184.01) (182.42) (184.00) (182.39) (185.04) (182.11) (180.85) (182.14) (180.82) (180.60) (180.79) (180.56) (180.63) (180.40) (180.35) (180.49) (179.76) (180.49) (179.67) (179.55) (179.91) (178.62) (179.52) (178.57) (178.84) (178.78) (178.10) (178.81) (177.90) (177.96) (177.49) (176.75) (177.73) (176.67) (175.58) (174.96) (175.05) (174.90) (175.33) (175.17) (171.41) (171.93) (171.46) (172.04) (172.85) (169.85) (169.45) (169.88) (169.48) (170.77) (169.42) (168.30) (169.46) (168.29) (169.97) (167.94) (168.07) (167.91) (168.03) (169.01) (164.93) (166.70) (165.10) (166.71) (166.82) (164.36) (164.47) (164.53) (164.47) (166.33) (163.62) (162.65) (163.71) (162.53) (164.69) (163.11) (162.08) (163.09) (162.11) (164.34) (162.81) (161.43) (162.80) (161.47) (162.70) (161.71) (160.77) (161.70) (160.80) (162.64) (161.06) (160.38) (161.06) (160.42) (162.51) (159.48) (159.54) (159.48) (159.67) (161.98) (159.04) (159.08) (159.18) (159.03) (160.45) (158.48) (158.76) (158.51) (158.66) (159.24) 12
13 Table S5. (continued) j R j, erg cm 3 (λ j, nm) (R,S)-6a7 (R,S)-6a8 (R,S)-6a9 (R,S)-6a10 (R,S)-6a (266.12) (265.31) (264.41) (265.85) (266.09) (258.40) (256.55) (252.45) (248.22) (249.42) (252.00) (250.74) (250.10) (243.50) (239.32) (239.37) (238.59) (239.67) (240.03) (239.02) (236.95) (233.74) (237.27) (239.11) (232.94) (235.09) (233.18) (234.91) (234.05) (231.72) (228.59) (227.49) (233.05) (230.27) (228.25) (224.22) (222.98) (229.22) (225.44) (222.67) (221.54) (220.83) (222.97) (223.63) (218.84) (218.99) (219.46) (218.61) (221.57) (216.11) (217.83) (218.71) (216.73) (219.32) (214.78) (215.07) (212.35) (213.49) (214.06) (213.93) (211.35) (211.96) (210.39) (211.97) (212.53) (210.35) (210.03) (208.44) (210.76) (208.20) (207.05) (207.61) (206.43) (207.18) (207.31) (206.48) (206.57) (205.84) (205.77) (204.66) (206.19) (204.79) (205.02) (202.39) (204.09) (203.99) (203.98) (202.04) (202.28) (203.61) (201.33) (201.42) (201.41) (200.70) (201.84) (200.09) (201.03) (198.96) (200.01) (199.43) (199.84) (200.16) (198.79) (198.12) (198.02) (195.00) (196.36) (196.92) (196.42) (196.69) (194.28) (194.07) (195.90) (195.14) (194.42) (193.77) (193.38) (194.88) (192.60) (193.17) (190.10) (189.07) (192.30) (191.71) (192.61) (188.12) (188.13) (189.33) (190.91) (192.32) (185.96) (186.07) (188.55) (188.50) (188.03) (185.28) (185.22) (187.01) (187.30) (185.40) (184.26) (184.61) (186.03) (183.22) (183.04) (181.90) (180.30) (184.79) (182.36) (182.34) (180.86) (180.17) (182.55) (181.97) (180.30) (180.61) (179.28) (181.42) (180.69) (179.97) (179.72) (178.73) (180.92) (180.31) (179.22) (178.98) (177.87) (180.06) (178.73) (177.81) (177.94) (175.41) (178.99) (178.04) (175.80) (176.89) (174.82) (176.47) (175.87) (174.59) (174.36) (172.85) (174.83) (174.80) (172.38) (173.01) (170.90) (173.83) (173.79) (168.45) (172.68) (169.01) (171.63) (171.34) (167.39) (170.15) (168.47) (171.42) (168.62) (166.71) (169.02) (166.50) (165.75) (168.26) (166.35) (166.72) (165.90) (164.65) (164.55) (163.66) (166.06) (164.43) (164.28) (164.31) (162.37) (164.65) (164.19) (164.15) (164.20) (161.58) (164.07) (162.24) (163.65) (163.22) (161.11) (163.82) (162.08) (163.25) (162.67) (160.44) (163.34) (161.73) (162.78) (162.35) (159.98) (163.13) (161.50) (161.92) (162.21) (159.85) (162.50) (160.04) (160.84) (161.95) (159.18) (160.93) (159.83) (160.58) (161.18) (158.13) 13
14 Table S5. (continued) j R j, erg cm 3 (λ j, nm) (R,S)-6a12 (R,S)-6a13 (R,S)-6a14 (R,S)-6a (267.65) (266.66) (262.97) (265.04) (257.14) (249.90) (251.64) (257.13) (247.12) (239.24) (246.50) (249.86) (239.84) (239.06) (239.13) (240.08) (234.38) (235.94) (233.92) (236.79) (233.07) (230.96) (232.68) (235.20) (230.00) (227.82) (226.66) (229.16) (223.28) (223.31) (224.53) (222.61) (221.12) (218.42) (218.33) (221.15) (220.41) (216.38) (214.53) (220.37) (217.69) (215.15) (213.67) (215.63) (215.93) (213.00) (212.15) (214.71) (213.25) (212.34) (209.85) (211.16) (211.30) (208.09) (209.37) (208.82) (208.69) (206.97) (209.06) (207.30) (205.24) (204.03) (206.63) (207.07) (204.33) (203.62) (204.19) (203.70) (202.09) (203.05) (203.74) (203.57) (200.88) (201.87) (202.09) (200.84) (199.75) (198.69) (199.15) (199.74) (199.63) (197.34) (198.50) (199.35) (195.40) (195.63) (198.09) (197.28) (194.26) (193.32) (197.27) (195.49) (192.80) (192.36) (195.14) (193.46) (190.55) (192.19) (191.11) (189.23) (188.70) (190.83) (188.83) (188.26) (188.06) (186.93) (187.80) (186.26) (184.86) (184.63) (186.41) (184.86) (182.80) (182.32) (185.61) (184.73) (181.18) (181.69) (183.15) (182.55) (181.11) (180.49) (180.31) (181.01) (180.09) (179.94) (180.08) (180.38) (178.42) (178.99) (179.71) (180.01) (178.03) (178.23) (179.53) (179.36) (177.60) (177.27) (178.05) (177.81) (175.59) (175.11) (177.14) (177.13) (174.86) (171.81) (173.42) (175.91) (171.37) (168.52) (172.15) (173.13) (170.71) (168.08) (170.03) (172.55) (169.77) (166.93) (169.31) (170.02) (168.66) (166.00) (165.48) (169.38) (167.77) (163.88) (164.46) (166.46) (166.09) (163.49) (163.74) (165.91) (165.01) (163.03) (163.31) (164.36) (164.36) (161.60) (163.00) (163.76) (163.52) (161.17) (162.54) (163.38) (163.33) (160.41) (162.27) (162.25) (161.97) (160.37) (161.73) (161.92) (161.85) (160.07) (160.59) (161.56) (160.96) (158.50) (160.36) (160.69) 14
15 Table S6. Oscillator strengths (f j ) and excitation wavelengths (λ j ) for the first 50 excited states of the conformers of compound (3R,4S)-6a, as obtained by PBE0/TZ2P//B97D/TZ2P calculations. j f j (λ j, nm) (R,S)-6a1 (R,S)-6a2 (R,S)-6a3 (R,S)-6a5 (R,S)-6a (262.71) (265.58) (262.91) (265.60) (265.25) (251.80) (249.24) (252.14) (249.35) (256.41) (248.84) (239.11) (248.87) (239.12) (250.63) (238.98) (238.75) (238.98) (238.75) (238.02) (234.69) (232.59) (235.03) (232.62) (233.62) (223.68) (229.11) (223.81) (229.21) (228.78) (222.96) (223.49) (222.98) (223.62) (223.14) (221.46) (222.83) (221.49) (222.74) (221.54) (216.83) (216.44) (216.79) (216.32) (219.59) (214.22) (215.89) (214.18) (215.92) (219.08) (213.13) (213.39) (213.12) (213.42) (217.83) (212.02) (212.25) (212.07) (212.24) (212.38) (210.06) (209.83) (210.03) (209.86) (210.36) (209.85) (208.75) (209.97) (208.69) (207.91) (206.77) (205.68) (206.96) (205.89) (207.78) (206.25) (204.73) (206.20) (204.53) (206.59) (205.12) (203.80) (205.12) (203.73) (204.90) (202.29) (203.27) (202.36) (203.40) (204.18) (200.56) (201.11) (200.68) (201.15) (201.22) (200.18) (199.25) (200.13) (199.30) (201.18) (198.78) (197.31) (198.80) (197.24) (200.43) (195.97) (195.16) (196.19) (195.23) (196.02) (194.09) (192.71) (194.20) (192.87) (194.13) (191.25) (192.31) (191.33) (192.42) (191.66) (188.17) (191.68) (188.28) (191.70) (189.09) (187.83) (188.98) (187.84) (188.99) (188.29) (186.52) (187.84) (186.55) (187.81) (186.37) (186.50) (184.29) (186.48) (184.23) (185.47) (184.01) (182.42) (184.00) (182.39) (185.04) (182.11) (180.85) (182.14) (180.82) (180.60) (180.79) (180.56) (180.63) (180.40) (180.35) (180.49) (179.76) (180.49) (179.67) (179.55) (179.91) (178.62) (179.52) (178.57) (178.84) (178.78) (178.10) (178.81) (177.90) (177.96) (177.49) (176.75) (177.73) (176.67) (175.58) (174.96) (175.05) (174.90) (175.33) (175.17) (171.41) (171.93) (171.46) (172.04) (172.85) (169.85) (169.45) (169.88) (169.48) (170.77) (169.42) (168.30) (169.46) (168.29) (169.97) (167.94) (168.07) (167.91) (168.03) (169.01) (164.93) (166.70) (165.10) (166.71) (166.82) (164.36) (164.47) (164.53) (164.47) (166.33) (163.62) (162.65) (163.71) (162.53) (164.69) (163.11) (162.08) (163.09) (162.11) (164.34) (162.81) (161.43) (162.80) (161.47) (162.70) (161.71) (160.77) (161.70) (160.80) (162.64) (161.06) (160.38) (161.06) (160.42) (162.51) (159.48) (159.54) (159.48) (159.67) (161.98) (159.04) (159.08) (159.18) (159.03) (160.45) (158.48) (158.76) (158.51) (158.66) (159.24) 15
16 Table S6. (continued) j f j (λ j, nm) (R,S)-6a7 (R,S)-6a8 (R,S)-6a9 (R,S)-6a10 (R,S)-6a (266.12) (265.31) (264.41) (265.85) (266.09) (258.40) (256.55) (252.45) (248.22) (249.42) (252.00) (250.74) (250.10) (243.50) (239.32) (239.37) (238.59) (239.67) (240.03) (239.02) (236.95) (233.74) (237.27) (239.11) (232.94) (235.09) (233.18) (234.91) (234.05) (231.72) (228.59) (227.49) (233.05) (230.27) (228.25) (224.22) (222.98) (229.22) (225.44) (222.67) (221.54) (220.83) (222.97) (223.63) (218.84) (218.99) (219.46) (218.61) (221.57) (216.11) (217.83) (218.71) (216.73) (219.32) (214.78) (215.07) (212.35) (213.49) (214.06) (213.93) (211.35) (211.96) (210.39) (211.97) (212.53) (210.35) (210.03) (208.44) (210.76) (208.20) (207.05) (207.61) (206.43) (207.18) (207.31) (206.48) (206.57) (205.84) (205.77) (204.66) (206.19) (204.79) (205.02) (202.39) (204.09) (203.99) (203.98) (202.04) (202.28) (203.61) (201.33) (201.42) (201.41) (200.70) (201.84) (200.09) (201.03) (198.96) (200.01) (199.43) (199.84) (200.16) (198.79) (198.12) (198.02) (195.00) (196.36) (196.92) (196.42) (196.69) (194.28) (194.07) (195.90) (195.14) (194.42) (193.77) (193.38) (194.88) (192.60) (193.17) (190.10) (189.07) (192.30) (191.71) (192.61) (188.12) (188.13) (189.33) (190.91) (192.32) (185.96) (186.07) (188.55) (188.50) (188.03) (185.28) (185.22) (187.01) (187.30) (185.40) (184.26) (184.61) (186.03) (183.22) (183.04) (181.90) (180.30) (184.79) (182.36) (182.34) (180.86) (180.17) (182.55) (181.97) (180.30) (180.61) (179.28) (181.42) (180.69) (179.97) (179.72) (178.73) (180.92) (180.31) (179.22) (178.98) (177.87) (180.06) (178.73) (177.81) (177.94) (175.41) (178.99) (178.04) (175.80) (176.89) (174.82) (176.47) (175.87) (174.59) (174.36) (172.85) (174.83) (174.80) (172.38) (173.01) (170.90) (173.83) (173.79) (168.45) (172.68) (169.01) (171.63) (171.34) (167.39) (170.15) (168.47) (171.42) (168.62) (166.71) (169.02) (166.50) (165.75) (168.26) (166.35) (166.72) (165.90) (164.65) (164.55) (163.66) (166.06) (164.43) (164.28) (164.31) (162.37) (164.65) (164.19) (164.15) (164.20) (161.58) (164.07) (162.24) (163.65) (163.22) (161.11) (163.82) (162.08) (163.25) (162.67) (160.44) (163.34) (161.73) (162.78) (162.35) (159.98) (163.13) (161.50) (161.92) (162.21) (159.85) (162.50) (160.04) (160.84) (161.95) (159.18) (160.93) (159.83) (160.58) (161.18) (158.13) 16
17 Table S6. (continued) j f j (λ j, nm) (R,S)-6a12 (R,S)-6a13 (R,S)-6a14 (R,S)-6a (267.65) (266.66) (262.97) (265.04) (257.14) (249.90) (251.64) (257.13) (247.12) (239.24) (246.50) (249.86) (239.84) (239.06) (239.13) (240.08) (234.38) (235.94) (233.92) (236.79) (233.07) (230.96) (232.68) (235.20) (230.00) (227.82) (226.66) (229.16) (223.28) (223.31) (224.53) (222.61) (221.12) (218.42) (218.33) (221.15) (220.41) (216.38) (214.53) (220.37) (217.69) (215.15) (213.67) (215.63) (215.93) (213.00) (212.15) (214.71) (213.25) (212.34) (209.85) (211.16) (211.30) (208.09) (209.37) (208.82) (208.69) (206.97) (209.06) (207.30) (205.24) (204.03) (206.63) (207.07) (204.33) (203.62) (204.19) (203.70) (202.09) (203.05) (203.74) (203.57) (200.88) (201.87) (202.09) (200.84) (199.75) (198.69) (199.15) (199.74) (199.63) (197.34) (198.50) (199.35) (195.40) (195.63) (198.09) (197.28) (194.26) (193.32) (197.27) (195.49) (192.80) (192.36) (195.14) (193.46) (190.55) (192.19) (191.11) (189.23) (188.70) (190.83) (188.83) (188.26) (188.06) (186.93) (187.80) (186.26) (184.86) (184.63) (186.41) (184.86) (182.80) (182.32) (185.61) (184.73) (181.18) (181.69) (183.15) (182.55) (181.11) (180.49) (180.31) (181.01) (180.09) (179.94) (180.08) (180.38) (178.42) (178.99) (179.71) (180.01) (178.03) (178.23) (179.53) (179.36) (177.60) (177.27) (178.05) (177.81) (175.59) (175.11) (177.14) (177.13) (174.86) (171.81) (173.42) (175.91) (171.37) (168.52) (172.15) (173.13) (170.71) (168.08) (170.03) (172.55) (169.77) (166.93) (169.31) (170.02) (168.66) (166.00) (165.48) (169.38) (167.77) (163.88) (164.46) (166.46) (166.09) (163.49) (163.74) (165.91) (165.01) (163.03) (163.31) (164.36) (164.36) (161.60) (163.00) (163.76) (163.52) (161.17) (162.54) (163.38) (163.33) (160.41) (162.27) (162.25) (161.97) (160.37) (161.73) (161.92) (161.85) (160.07) (160.59) (161.56) (160.96) (158.50) (160.36) (160.69) 17
18 1 H and 13 C NMR spectra of compounds (±)-5a, (±)-6a and (±)-4a 18
19 19
20 20
21 Elemental Analysis Compound Formula Calcd Found C H N C H N 4a C 24 H 22 FN 5 O b C 28 H 24 FN 3 O c C 25 H 23 FN 4 O d C 25 H 21 F 7 N 2 O e C 25 H 25 N 5 O f C 26 H 29 N 5 O g C 27 H 31 N 5 O h C 25 H 27 N 5 O a C 28 H 27 FN 2 O a C 21 H 21 FN 2 O C 24 H 24 FN 5 O C 16 H 12 FNO C 8 H 12 N 4 O REFERENCES (1) Di Marzo, V.; Stella, N.; Zimmer, A.; Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci 2015, 16,
MS-based proteomics to investigate proteins and their modifications
MS-based proteomics to investigate proteins and their modifications Francis Impens VIB Proteomics Core October th 217 Overview Mass spectrometry-based proteomics: general workflow Identification of protein
More information4 Examples of enzymes
Catalysis 1 4 Examples of enzymes Adding water to a substrate: Serine proteases. Carbonic anhydrase. Restrictions Endonuclease. Transfer of a Phosphoryl group from ATP to a nucleotide. Nucleoside monophosphate
More informationDiscussion Section (Day, Time): TF:
ame: Chemistry 27 Professor Gavin MacBeath arvard University Spring 2004 Final Exam Thursday, May 28, 2004 2:15 PM - 5:15 PM Discussion Section (Day, Time): Directions: TF: 1. Do not write in red ink.
More informationNMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease
University of Wollongong Research Online Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 2009 NMR study of complexes between low molecular mass inhibitors and the West Nile
More informationMethods for proteome analysis of obesity (Adipose tissue)
Methods for proteome analysis of obesity (Adipose tissue) I. Sample preparation and liquid chromatography-tandem mass spectrometric analysis Instruments, softwares, and materials AB SCIEX Triple TOF 5600
More informationFigure S1. Interaction of PcTS with αsyn. (a) 1 H- 15 N HSQC NMR spectra of 100 µm αsyn in the absence (0:1, black) and increasing equivalent
Figure S1. Interaction of PcTS with αsyn. (a) 1 H- 15 N HSQC NMR spectra of 100 µm αsyn in the absence (0:1, black) and increasing equivalent concentrations of PcTS (100 µm, blue; 500 µm, green; 1.5 mm,
More informationRapid and Sensitive Fluorescent Peptide Quantification Using LavaPep
Rapid and Sensitive Fluorescent Peptide Quantification Using LavaPep Purpose To develop a fast, sensitive and robust fluorescent-based assay, to quantify peptides that is compatible with downstream proteomics
More informationModeling Mass Spectrometry-Based Protein Analysis
Chapter 8 Jan Eriksson and David Fenyö Abstract The success of mass spectrometry based proteomics depends on efficient methods for data analysis. These methods require a detailed understanding of the information
More informationDesign of Enzyme Literature Seminar Yun-wei Xue
Design of Enzyme 20180714 Literature Seminar Yun-wei Xue 1 Contents 1. Introduction 2. De novo design 3. Incorporation of unnatural amino acid (main paper) 2 1.1 Advantages and limitations of natural enzyme
More informationSupplemental Information. Molecular Basis of Spectral Diversity. in Near-Infrared Phytochrome-Based. Fluorescent Proteins
Chemistry & Biology, Volume 22 Supplemental Information Molecular Basis of Spectral Diversity in Near-Infrared Phytochrome-Based Fluorescent Proteins Daria M. Shcherbakova, Mikhail Baloban, Sergei Pletnev,
More informationSupporting Information
Electronic Supplementary Material (ESI) for Dalton Transactions. This journal is The Royal Society of Chemistry 2017 ROS-mediated Carbon Monoxide and Drug Release from Drug-conjugated Carboxyboranes Theppawut
More informationReagents. Affinity Tag (Biotin) Acid Cleavage Site. Figure 1. Cleavable ICAT Reagent Structure.
DATA SHEET Protein Expression Analysis Reagents Background The ultimate goal of proteomics is to identify and quantify proteins that are relevant to a given biological state; and to unearth networks of
More informationA primer on pharmacology pharmacodynamics
A primer on pharmacology pharmacodynamics Drug binding & effect Universidade do Algarve Faro 2017 by Ferdi Engels, Ph.D. 1 Pharmacodynamics Relation with pharmacokinetics? dosage plasma concentration site
More informationCOMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS
COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS DRUG DEVELOPMENT Drug development is a challenging path Today, the causes of many diseases (rheumatoid arthritis, cancer, mental diseases, etc.)
More informationQuantitative Proteomics
Quantitative Proteomics Quantitation AND Mass Spectrometry Condition A Condition B Identify and quantify differently expressed proteins resulting from a change in the environment (stimulus, disease) Lyse
More informationGyörgy M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences
Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules
More informationFall Organic Chemistry Experiment #6 Fractional Crystallization (Resolution of Enantiomers)
Suggested Reading: Fall Organic Chemistry Experiment #6 Fractional Crystallization (Resolution of Enantiomers) Jones Section 4.9 Physical Properties of Diastereomers: Optical Resolution pages 176-178 Introduction
More informationDocking. GBCB 5874: Problem Solving in GBCB
Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular
More informationState Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical
Electronic Supplementary Information Evidence for inhibition of HIF-1α Prolyl hydroxylase 3 activity by four biological active tetraazamacrocycles Jing Cao, Zhirong Geng, Xiaoyan Ma, Jinghan Wen, Yuxin
More information2015 AP Biology Unit 2 PRETEST- Introduction to the Cell and Biochemistry
Name: Class: _ Date: _ 2015 AP Biology Unit 2 PRETEST- Introduction to the Cell and Biochemistry Multiple Choice Identify the choice that best completes the statement or answers the question. 1) In what
More informationImproved 6- Plex TMT Quantification Throughput Using a Linear Ion Trap HCD MS 3 Scan Jane M. Liu, 1,2 * Michael J. Sweredoski, 2 Sonja Hess 2 *
Improved 6- Plex TMT Quantification Throughput Using a Linear Ion Trap HCD MS 3 Scan Jane M. Liu, 1,2 * Michael J. Sweredoski, 2 Sonja Hess 2 * 1 Department of Chemistry, Pomona College, Claremont, California
More informationBSc and MSc Degree Examinations
Examination Candidate Number: Desk Number: BSc and MSc Degree Examinations 2018-9 Department : BIOLOGY Title of Exam: Molecular Biology and Biochemistry Part I Time Allowed: 1 hour and 30 minutes Marking
More informationBiomolecules: lecture 10
Biomolecules: lecture 10 - understanding in detail how protein 3D structures form - realize that protein molecules are not static wire models but instead dynamic, where in principle every atom moves (yet
More informationBackground on Solubility
CHEM254 01 Open Notebook Science Solubility Challenge 1 For the first laboratory exercise of this semester we are going to participate in the Open Notebook Science (ONS) solubility challenge http://onschallenge.wikispaces.com/.
More informationChapter 6. The interaction of Src SH2 with the focal adhesion kinase catalytic domain studied by NMR
The interaction of Src SH2 with the focal adhesion kinase catalytic domain studied by NMR 103 Abstract The interaction of the Src SH2 domain with the catalytic domain of FAK, including the Y397 SH2 domain
More informationBiochemistry 3100 Sample Problems Binding proteins, Kinetics & Catalysis
(1) Draw an approximate denaturation curve for a typical blood protein (eg myoglobin) as a function of ph. (2) Myoglobin is a simple, single subunit binding protein that has an oxygen storage function
More informationIsothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017
Isothermal Titration Calorimetry in Drug Discovery Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 217 Introduction Introduction to ITC Strengths / weaknesses & what is required
More informationInterpretation of Organic Spectra. Chem 4361/8361
Interpretation of Organic Spectra Chem 4361/8361 Characteristics of Common Spectrometric Methods H-1 C-13 MS IR/RAMAN UV-VIS ORD/CD X- RAY Radiation type RF RF Not relevant IR UV to visible UV to visible
More informationEnzyme function: the transition state. Enzymes & Kinetics V: Mechanisms. Catalytic Reactions. Margaret A. Daugherty A B. Lecture 16: Fall 2003
Lecture 16: Enzymes & Kinetics V: Mechanisms Margaret A. Daugherty Fall 2003 Enzyme function: the transition state Catalytic Reactions A B Catalysts (e.g. enzymes) act by lowering the transition state
More informationCatalytic Reactions. Intermediate State in Catalysis. Lecture 16: Catalyzed reaction. Uncatalyzed reaction. Enzymes & Kinetics V: Mechanisms
Enzyme function: the transition state Catalytic Reactions Lecture 16: Enzymes & Kinetics V: Mechanisms Margaret A. Daugherty Fall 2003 A B Catalysts (e.g. enzymes) act by lowering the transition state
More informationReceptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
More informationChem 204. Mid-Term Exam I. July 21, There are 3 sections to this exam: Answer ALL questions
Chem 204 Mid-Term Exam I July 21, 2009 Name: Answer Key Student ID: There are 3 sections to this exam: Answer ALL questions Section I: Multiple-Choice 20 questions, 2 pts each Section II: Fill-in-the-Blank
More informationSupporting Information
Supporting Information Micelle-Triggered b-hairpin to a-helix Transition in a 14-Residue Peptide from a Choline-Binding Repeat of the Pneumococcal Autolysin LytA HØctor Zamora-Carreras, [a] Beatriz Maestro,
More informationNPTEL VIDEO COURSE PROTEOMICS PROF. SANJEEVA SRIVASTAVA
LECTURE-25 Quantitative proteomics: itraq and TMT TRANSCRIPT Welcome to the proteomics course. Today we will talk about quantitative proteomics and discuss about itraq and TMT techniques. The quantitative
More informationMicrocalorimetry for the Life Sciences
Microcalorimetry for the Life Sciences Why Microcalorimetry? Microcalorimetry is universal detector Heat is generated or absorbed in every chemical process In-solution No molecular weight limitations Label-free
More informationChemistry Instrumental Analysis Lecture 37. Chem 4631
Chemistry 4631 Instrumental Analysis Lecture 37 Most analytes separated by HPLC are thermally stable and non-volatile (liquids) (unlike in GC) so not ionized easily by EI or CI techniques. MS must be at
More informationCH 3 CH 2 OH +H 2 O CHO. 2e + 2H + + O 2 H 2 O +HCOOH
2 4 H CH 3 2e + 2H + + 2 H 2 2 H CH 2 H 2e + 2H + + 2 H 2 2 H +H 2 CH 2e + 2H + + 2 H 2 2 H +HCH Supplemental Figure S. The three-step 4DM reaction, each step requires two reducing equivalents from ADPH
More informationChapter 5. Complexation of Tholins by 18-crown-6:
5-1 Chapter 5. Complexation of Tholins by 18-crown-6: Identification of Primary Amines 5.1. Introduction Electrospray ionization (ESI) is an excellent technique for the ionization of complex mixtures,
More informationEnzymes Enzyme Mechanism
Mechanisms of Enzymes BCMB 3100 Chapters 6, 7, 8 Enzymes Enzyme Mechanism 1 Energy diagrams Binding modes of enzyme catalysis Chemical modes of enzyme catalysis Acid-Base catalysis Covalent catalysis Binding
More informationCentral Dogma. modifications genome transcriptome proteome
entral Dogma DA ma protein post-translational modifications genome transcriptome proteome 83 ierarchy of Protein Structure 20 Amino Acids There are 20 n possible sequences for a protein of n residues!
More informationSupplementary Figure 1. Structures of substrates tested with 1. Only one enantiomer is shown.
Supplementary Figure 1. Structures of substrates tested with 1. Only one enantiomer is shown. Supplementary Figure 2. CD spectra obtained using 1 and (R)-3 (blue) and (S)-3 (red) Supplementary Figure 3.
More informationSupporting Information
Supporting Information Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5 diaryl pyrazole inhibitors. Franco Chimenti, a Rossella Fioravanti,* a Adriana Bolasco, a Fedele
More informationEnzymes Enzyme Mechanism
BCMB 3100 Chapters 6, 7, 8 Enzymes Enzyme Mechanism 1 Mechanisms of Enzymes Energy diagrams Binding modes of enzyme catalysis Chemical modes of enzyme catalysis Acid-Base catalysis Covalent catalysis Binding
More informationDegree of labeling (DOL)
Degree of labeling (DOL) A written explanation for the determination of the degree of labeling when using NuLink reagents. The DOL is the average number of reagent molecules that have been covalently attached
More informationProtein Quantitation II: Multiple Reaction Monitoring. Kelly Ruggles New York University
Protein Quantitation II: Multiple Reaction Monitoring Kelly Ruggles kelly@fenyolab.org New York University Traditional Affinity-based proteomics Use antibodies to quantify proteins Western Blot RPPA Immunohistochemistry
More informationProtein Structure. W. M. Grogan, Ph.D. OBJECTIVES
Protein Structure W. M. Grogan, Ph.D. OBJECTIVES 1. Describe the structure and characteristic properties of typical proteins. 2. List and describe the four levels of structure found in proteins. 3. Relate
More informationConformational Analysis
Conformational Analysis C01 3 C C 3 is the most stable by 0.9 kcal/mole C02 K eq = K 1-1 * K 2 = 0.45-1 * 0.048 = 0.11 C04 The intermediate in the reaction of 2 has an unfavorable syn-pentane interaction,
More informationC a h p a t p e t r e r 6 E z n y z m y e m s
Chapter 6 Enzymes 4. Examples of enzymatic reactions acid-base catalysis: give and take protons covalent catalysis: a transient covalent bond is formed between the enzyme and the substrate metal ion catalysis:
More informationApplication Note. Authors. Introduction. Lauren E. Frick and William A. LaMarr Agilent Technologies, Inc. Wakefield, MA, USA
Fragment-Based Drug Discovery: Comparing Labeled and Label-Free Screening of β-amyloid Secretase (BACE-1) Using Fluorescence Spectroscopy and Ultrafast SPE/MS/MS Application Note Authors Lauren E. Frick
More information240 Chem. Stereochemistry. Chapter 5
240 Chem Stereochemistry Chapter 5 1 Isomerism Isomers are different compounds that have the same molecular formula. Constitutional isomers are isomers that differ because their atoms are connected in
More informationProtein Structure Analysis and Verification. Course S Basics for Biosystems of the Cell exercise work. Maija Nevala, BIO, 67485U 16.1.
Protein Structure Analysis and Verification Course S-114.2500 Basics for Biosystems of the Cell exercise work Maija Nevala, BIO, 67485U 16.1.2008 1. Preface When faced with an unknown protein, scientists
More information5-Hydroxymethylcytosine-selective oxidation with peroxotungstate
Supporting Information 5-Hydroxymethylcytosine-selective oxidation with peroxotungstate Akimitsu Okamoto, 1,2,* Kaori Sugizaki, 1 Akiko Nakamura, 1 Hiroyuki Yanagisawa, 1 Shuji Ikeda 1 1 Advanced Science
More informationZ -LYTE Assay Setup Guide on the BMG LABTECH CLARIOstar Reader
08 Jan 15 Page 1 of 18 Z -LYTE Assay Setup Guide on the BMG LABTECH CLARIOstar Reader The BMG LABTECH CLARIOstar Microplate Readers were tested for compatibility with the Life Technologies Z -LYTE Assay
More informationSerine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition
Supplementary Information to Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition Nadine Czudnochowski 1,2, *, Christian A. Bösken 1, * & Matthias Geyer 1 1 Max-Planck-Institut
More informationIt is generally believed that the catalytic reactions occur in at least two steps.
Lecture 16 MECHANISM OF ENZYME ACTION A chemical reaction such as A ----> P takes place because a certain fraction of the substrate possesses enough energy to attain an activated condition called the transition
More informationSupplemental Data. Structure of the Rb C-Terminal Domain. Bound to E2F1-DP1: A Mechanism. for Phosphorylation-Induced E2F Release
Supplemental Data Structure of the Rb C-Terminal Domain Bound to E2F1-DP1: A Mechanism for Phosphorylation-Induced E2F Release Seth M. Rubin, Anne-Laure Gall, Ning Zheng, and Nikola P. Pavletich Section
More informationCaspase-1 Specific Light-up Probe with Aggregation-Induced Emission. Characteristics for Inhibitor Screening of Coumarin-Originated Natural.
Supporting Information Caspase-1 Specific Light-up Probe with Aggregation-Induced Emission Characteristics for Inhibitor Screening of Coumarin-Originated Natural Products Hao Lin, ^ Haitao Yang, ^ Shuai
More informationЖ У Р Н А Л С Т Р У К Т У Р Н О Й Х И М И И Том 50, 5 Сентябрь октябрь С
Ж У Р Н А Л С Т Р У К Т У Р Н О Й Х И М И И 2009. Том 50, 5 Сентябрь октябрь С. 873 877 UDK 539.27 STRUCTURAL STUDIES OF L-SERYL-L-HISTIDINE DIPEPTIDE BY MEANS OF MOLECULAR MODELING, DFT AND 1 H NMR SPECTROSCOPY
More informationNonlinear pharmacokinetics
5 Nonlinear pharmacokinetics 5 Introduction 33 5 Capacity-limited metabolism 35 53 Estimation of Michaelis Menten parameters(v max andk m ) 37 55 Time to reach a given fraction of steady state 56 Example:
More informationProtein Quantitation II: Multiple Reaction Monitoring. Kelly Ruggles New York University
Protein Quantitation II: Multiple Reaction Monitoring Kelly Ruggles kelly@fenyolab.org New York University Traditional Affinity-based proteomics Use antibodies to quantify proteins Western Blot Immunohistochemistry
More informationOrganic Chemistry FINAL EXAM A (250 points)
UCSC, Binder ame Student ID # Section Day/Time rganic Chemistry FIAL EXAM A (250 points) D T BEGI TE EXAM R TUR TE PAGE UTIL ISTRUCTED T D S. In the meantime, please read the instructions below. In each
More informationTracking Protein Allostery in Evolution
Tracking Protein Allostery in Evolution Glycogen phosphorylase frees sugars to provide energy GP orthologs diverged 600,000,000 years can respond to transcription controls, metabolite concentrations and
More informationAbsorbance (a. u.) Wavelength (nm) Wavelength (nm) Intensity (a. u.) Wavelength (nm) Wavelength (nm)
Intensity (a. u.) Absorbance (a. u.) a UV UV b Wavelength (nm) Wavelength (nm) UV UV Wavelength (nm) Wavelength (nm) Supplementary Figure 1. UV-Vis absorbance spectral changes of (a) SP-Gal (left, 10 μm),
More informationAssignment 1: Molecular Mechanics (PART 1 25 points)
Chemistry 380.37 Fall 2015 Dr. Jean M. Standard August 19, 2015 Assignment 1: Molecular Mechanics (PART 1 25 points) In this assignment, you will perform some molecular mechanics calculations using the
More informationLec.1 Chemistry Of Water
Lec.1 Chemistry Of Water Biochemistry & Medicine Biochemistry can be defined as the science concerned with the chemical basis of life. Biochemistry can be described as the science concerned with the chemical
More informationProtein Folding & Stability. Lecture 11: Margaret A. Daugherty. Fall How do we go from an unfolded polypeptide chain to a
Lecture 11: Protein Folding & Stability Margaret A. Daugherty Fall 2004 How do we go from an unfolded polypeptide chain to a compact folded protein? (Folding of thioredoxin, F. Richards) Structure - Function
More informationCharacterization of Reversible Kinase Inhibitors using Microfluidic Mobility-Shift Assays
Application Note 211 Characterization of Reversible Kinase Inhibitors using Microfluidic Mobility-Shift Assays Introduction Current drug discovery efforts typically focus on developing small molecule inhibitors
More informationIntroduction to FBDD Fragment screening methods and library design
Introduction to FBDD Fragment screening methods and library design Samantha Hughes, PhD Fragments 2013 RSC BMCS Workshop 3 rd March 2013 Copyright 2013 Galapagos NV Why fragment screening methods? Guess
More informationImplementation of novel tools to facilitate fragment-based drug discovery by NMR:
Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry
More informationSupporting information. An improved photo-induced fluorogenic alkene-tetrazole reaction for protein labeling
Supporting information An improved photo-induced fluorogenic alkene-tetrazole reaction for protein labeling X. Shang, 1 R. Lai, 1,3 X. Song, 1 H. Li, 1,3 W. Niu, 2 and J. Guo 1 * 1. Department of Chemistry,
More information1. Amino Acids and Peptides Structures and Properties
1. Amino Acids and Peptides Structures and Properties Chemical nature of amino acids The!-amino acids in peptides and proteins (excluding proline) consist of a carboxylic acid ( COOH) and an amino ( NH
More informationDetailed description of overall and active site architecture of PPDC- 3dThDP, PPDC-2HE3dThDP, PPDC-3dThDP-PPA and PPDC- 3dThDP-POVA
Online Supplemental Results Detailed description of overall and active site architecture of PPDC- 3dThDP, PPDC-2HE3dThDP, PPDC-3dThDP-PPA and PPDC- 3dThDP-POVA Structure solution and overall architecture
More informationChapter 4. strategies for protein quantitation Ⅱ
Proteomics Chapter 4. strategies for protein quantitation Ⅱ 1 Multiplexed proteomics Multiplexed proteomics is the use of fluorescent stains or probes with different excitation and emission spectra to
More informationComputational Methods for Mass Spectrometry Proteomics
Computational Methods for Mass Spectrometry Proteomics Eidhammer, Ingvar ISBN-13: 9780470512975 Table of Contents Preface. Acknowledgements. 1 Protein, Proteome, and Proteomics. 1.1 Primary goals for studying
More informationElectronic Supplementary Information. for
Electronic Supplementary Material (ESI) for Chemical Science. This journal is The Royal Society of Chemistry 2018 Electronic Supplementary Information for Two Chiral Catalysts in Action: Insights on Cooperativity
More informationSUPPLEMENTARY INFORMATION
Figure S1. Secondary structure of CAP (in the camp 2 -bound state) 10. α-helices are shown as cylinders and β- strands as arrows. Labeling of secondary structure is indicated. CDB, DBD and the hinge are
More informationTargeting protein-protein interactions: A hot topic in drug discovery
Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,
More informationKang, Lin-Woo, Ph.D. Professor Department of Biological Sciences Konkuk University Seoul, Korea nd Semester
Kang, Lin-Woo, Ph.D. Professor Department of Biological Sciences Konkuk University Seoul, Korea 2018. 2 nd Semester Absorbance Assay (280 nm) Considerations for use Absorbance assays are fast and
More informationActa Crystallographica Section D
Supporting information Acta Crystallographica Section D Volume 70 (2014) Supporting information for article: Structural characterization of the virulence factor Nuclease A from Streptococcus agalactiae
More informationLa RMN quantitative appliquée aux petites molécules
La RMN quantitative appliquée aux petites molécules Fabrice Moriaud - Applications Development - Fällanden 30ème Réunion d Utilisateurs RMN Bruker December 9, 2016 1 Covered in this presentation Quantification
More informationBiology Exam: Chapters 6 & 7
Biology Exam: Chapters 6 & 7 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Which of the following compounds may be polymers? A) carbohydrates C) proteins
More informationLecture 15: Enzymes & Kinetics. Mechanisms ROLE OF THE TRANSITION STATE. H-O-H + Cl - H-O δ- H Cl δ- HO - + H-Cl. Margaret A. Daugherty.
Lecture 15: Enzymes & Kinetics Mechanisms Margaret A. Daugherty Fall 2004 ROLE OF THE TRANSITION STATE Consider the reaction: H-O-H + Cl - H-O δ- H Cl δ- HO - + H-Cl Reactants Transition state Products
More informationPeptide & Protein Quantification Kit, with RED EpicoccoStab for the accurate and sensitive determination of peptides, as well proteins
Peptide & Protein Quantification Kit, with RED EpicoccoStab for the accurate and sensitive determination of peptides, as well proteins Description Catalog #: CH4191, 1 kit up to 2000 assays Name: Protein&Peptide
More informationSupplementary Figure 3 a. Structural comparison between the two determined structures for the IL 23:MA12 complex. The overall RMSD between the two
Supplementary Figure 1. Biopanningg and clone enrichment of Alphabody binders against human IL 23. Positive clones in i phage ELISA with optical density (OD) 3 times higher than background are shown for
More informationBCMP 201 Protein biochemistry
BCMP 201 Protein biochemistry BCMP 201 Protein biochemistry with emphasis on the interrelated roles of protein structure, catalytic activity, and macromolecular interactions in biological processes. The
More informationRetrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
More informationIdentifying Interaction Hot Spots with SuperStar
Identifying Interaction Hot Spots with SuperStar Version 1.0 November 2017 Table of Contents Identifying Interaction Hot Spots with SuperStar... 2 Case Study... 3 Introduction... 3 Generate SuperStar Maps
More informationLecture 11: Enzymes: Kinetics [PDF] Reading: Berg, Tymoczko & Stryer, Chapter 8, pp
Lecture 11: Enzymes: Kinetics [PDF] Reading: Berg, Tymoczko & Stryer, Chapter 8, pp. 216-225 Updated on: 2/4/07 at 9:00 pm Key Concepts Kinetics is the study of reaction rates. Study of enzyme kinetics
More informationSupporting Information. for
Supporting Information for Near-Infrared Fluorescent Turn-On Probe with a Remarkable Large Stokes Shift for Imaging Selenocysteine in Living Cells and Animals Weiyong Feng, Meixing Li, Yao Sun, and Guoqiang
More informationEnamine Golden Fragment Library
Enamine Golden Fragment Library 14 March 216 1794 compounds deliverable as entire set or as selected items. Fragment Based Drug Discovery (FBDD) [1,2] demonstrates remarkable results: more than 3 compounds
More informationSupporting Information
Supporting Information Ottmann et al. 10.1073/pnas.0907587106 Fig. S1. Primary structure alignment of SBT3 with C5 peptidase from Streptococcus pyogenes. The Matchmaker tool in UCSF Chimera (http:// www.cgl.ucsf.edu/chimera)
More informationLecture 11: Protein Folding & Stability
Structure - Function Protein Folding: What we know Lecture 11: Protein Folding & Stability 1). Amino acid sequence dictates structure. 2). The native structure represents the lowest energy state for a
More informationProtein Folding & Stability. Lecture 11: Margaret A. Daugherty. Fall Protein Folding: What we know. Protein Folding
Lecture 11: Protein Folding & Stability Margaret A. Daugherty Fall 2003 Structure - Function Protein Folding: What we know 1). Amino acid sequence dictates structure. 2). The native structure represents
More informationStructure based drug design and LIE models for GPCRs
Structure based drug design and LIE models for GPCRs Peter Kolb kolb@docking.org Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser
More informationCHEM-UA 652: Thermodynamics and Kinetics
1 CHEM-UA 652: Thermodynamics and Kinetics Notes for Lecture 11 I. PHYSICAL AND CHEMICAL RELEVANCE OF FREE ENERGY In this section, we will consider some examples showing the significance of free energies.
More informationElectron Transfer Dissociation of N-linked Glycopeptides from a Recombinant mab Using SYNAPT G2-S HDMS
Electron Transfer Dissociation of N-linked Glycopeptides from a Recombinant mab Using SYNAPT G2-S HDMS Jonathan P. Williams, Jeffery M. Brown, Stephane Houel, Ying Qing Yu, and Weibin Chen Waters Corporation,
More informationSupplementary Figure 1. SDS-PAGE analysis of GFP oligomer variants with different linkers. Oligomer mixtures were applied to a PAGE gel containing
Supplementary Figure 1. SDS-PAGE analysis of GFP oligomer variants with different linkers. Oligomer mixtures were applied to a PAGE gel containing 0.1% SDS without boiling. The gel was analyzed by a fluorescent
More informationSupporting Information
S-1 Supporting Information Flaviviral protease inhibitors identied by fragment-based library docking into a structure generated by molecular dynamics Dariusz Ekonomiuk a, Xun-Cheng Su b, Kiyoshi Ozawa
More informationStructural Basis of Multivalent Binding to Wheat Germ Agglutinin
Structural Basis of Multivalent Binding to Wheat Germ Agglutinin David Schwefel, Caroline Maierhofer, Johannes G. Beck, Sonja Seeberger, Kay Diederichs, Heiko M. Möller,*, Wolfram Welte,*, and Valentin
More informationBackbone modification of a parathyroid hormone receptor-1 antagonist/inverse agonist
SUPPORTING INFORMATION Backbone modification of a parathyroid hormone receptor-1 antagonist/inverse agonist Ross W. Cheloha, Tomoyuki Watanabe, Thomas Dean, Samuel H. Gellman*, Thomas J. Gardella* *Corresponding
More information